Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration

Abstract Background Evidence from observational studies suggests an association between chronic obstructive pulmonary disease (COPD) and lung cancer. The potential interactions between the immune system and the lungs may play a causative role in COPD and lung cancer and offer therapeutic prospects....

Full description

Bibliographic Details
Main Authors: Dengfeng Zhang, Haitao Liu, Fangchao Zhao, Pengfei Guo, Jing Li, Tianxing Lu, Zhirong Li, Shujun Li
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-12076-1
_version_ 1797209280870350848
author Dengfeng Zhang
Haitao Liu
Fangchao Zhao
Pengfei Guo
Jing Li
Tianxing Lu
Zhirong Li
Shujun Li
author_facet Dengfeng Zhang
Haitao Liu
Fangchao Zhao
Pengfei Guo
Jing Li
Tianxing Lu
Zhirong Li
Shujun Li
author_sort Dengfeng Zhang
collection DOAJ
description Abstract Background Evidence from observational studies suggests an association between chronic obstructive pulmonary disease (COPD) and lung cancer. The potential interactions between the immune system and the lungs may play a causative role in COPD and lung cancer and offer therapeutic prospects. However, the causal association and the immune-mediated mechanisms between COPD and lung cancer remain to be determined. Methods We employed a two-sample Mendelian randomization (MR) approach to investigate the causal association between COPD and lung cancer. Additionally, we examined whether immune cell signals were causally related to lung cancer, as well as whether COPD was causally associated with immune cell signals. Furthermore, through two-step Mendelian randomization, we investigated the mediating effects of immune cell signals in the causal association between COPD and lung cancer. Leveraging publicly available genetic data, our analysis included 468,475 individuals of European ancestry with COPD, 492,803 individuals of European ancestry with lung cancer, and 731 immune cell signatures of European ancestry. Additionally, we conducted single-cell transcriptome sequencing analysis on COPD, lung cancer, and control samples to validate our findings. Findings We found a causal association between COPD and lung cancer (odds ratio [OR] = 1.63, 95% confidence interval [CI] = 1.31–2.02, P-value < 0.001). We also observed a causal association between COPD and regulatory T cells (odds ratio [OR] = 1.19, 95% confidence interval [CI] = 1.01–1.40, P-value < 0.05), as well as a causal association between regulatory T cells and lung cancer (odds ratio [OR] = 1.02, 95% confidence interval [CI] = 1.002–1.045, P-value < 0.05). Furthermore, our two-step Mendelian randomization analysis demonstrated that COPD is associated with lung cancer through the mediation of regulatory T cells. These findings were further validated through single-cell sequencing analysis, confirming the mediating role of regulatory T cells in the association between COPD and lung cancer. Interpretation As far as we are aware, we are the first to combine single-celled immune cell data with two-sample Mendelian randomization. Our analysis indicates a causal association between COPD and lung cancer, with regulatory T cells playing an intermediary role.
first_indexed 2024-04-24T09:52:12Z
format Article
id doaj.art-6531661ff4e14cc5842c38e3ab0d209b
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-24T09:52:12Z
publishDate 2024-04-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-6531661ff4e14cc5842c38e3ab0d209b2024-04-14T11:18:55ZengBMCBMC Cancer1471-24072024-04-012411910.1186/s12885-024-12076-1Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integrationDengfeng Zhang0Haitao Liu1Fangchao Zhao2Pengfei Guo3Jing Li4Tianxing Lu5Zhirong Li6Shujun Li7Provincial Center for Clinical Laboratories,Department of Thoracic Surgery, The Second Hospital of Hebei Medical UniversityCollege of Life Science, Inner Mongolia UniversityProvincial Center for Clinical Laboratories,Department of Thoracic Surgery, The Second Hospital of Hebei Medical UniversityProvincial Center for Clinical Laboratories,Department of Thoracic Surgery, The Second Hospital of Hebei Medical UniversityProvincial Center for Clinical Laboratories,Department of Thoracic Surgery, The Second Hospital of Hebei Medical UniversityProvincial Center for Clinical Laboratories,Department of Thoracic Surgery, The Second Hospital of Hebei Medical UniversityProvincial Center for Clinical Laboratories,Department of Thoracic Surgery, The Second Hospital of Hebei Medical UniversityProvincial Center for Clinical Laboratories,Department of Thoracic Surgery, The Second Hospital of Hebei Medical UniversityAbstract Background Evidence from observational studies suggests an association between chronic obstructive pulmonary disease (COPD) and lung cancer. The potential interactions between the immune system and the lungs may play a causative role in COPD and lung cancer and offer therapeutic prospects. However, the causal association and the immune-mediated mechanisms between COPD and lung cancer remain to be determined. Methods We employed a two-sample Mendelian randomization (MR) approach to investigate the causal association between COPD and lung cancer. Additionally, we examined whether immune cell signals were causally related to lung cancer, as well as whether COPD was causally associated with immune cell signals. Furthermore, through two-step Mendelian randomization, we investigated the mediating effects of immune cell signals in the causal association between COPD and lung cancer. Leveraging publicly available genetic data, our analysis included 468,475 individuals of European ancestry with COPD, 492,803 individuals of European ancestry with lung cancer, and 731 immune cell signatures of European ancestry. Additionally, we conducted single-cell transcriptome sequencing analysis on COPD, lung cancer, and control samples to validate our findings. Findings We found a causal association between COPD and lung cancer (odds ratio [OR] = 1.63, 95% confidence interval [CI] = 1.31–2.02, P-value < 0.001). We also observed a causal association between COPD and regulatory T cells (odds ratio [OR] = 1.19, 95% confidence interval [CI] = 1.01–1.40, P-value < 0.05), as well as a causal association between regulatory T cells and lung cancer (odds ratio [OR] = 1.02, 95% confidence interval [CI] = 1.002–1.045, P-value < 0.05). Furthermore, our two-step Mendelian randomization analysis demonstrated that COPD is associated with lung cancer through the mediation of regulatory T cells. These findings were further validated through single-cell sequencing analysis, confirming the mediating role of regulatory T cells in the association between COPD and lung cancer. Interpretation As far as we are aware, we are the first to combine single-celled immune cell data with two-sample Mendelian randomization. Our analysis indicates a causal association between COPD and lung cancer, with regulatory T cells playing an intermediary role.https://doi.org/10.1186/s12885-024-12076-1scRNA-seqMendelian randomizationLung cancerRegulatory T cellsChronic obstructive Pulmonary disease
spellingShingle Dengfeng Zhang
Haitao Liu
Fangchao Zhao
Pengfei Guo
Jing Li
Tianxing Lu
Zhirong Li
Shujun Li
Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration
BMC Cancer
scRNA-seq
Mendelian randomization
Lung cancer
Regulatory T cells
Chronic obstructive Pulmonary disease
title Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration
title_full Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration
title_fullStr Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration
title_full_unstemmed Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration
title_short Exploring the relationship between Treg-mediated risk in COPD and lung cancer through Mendelian randomization analysis and scRNA-seq data integration
title_sort exploring the relationship between treg mediated risk in copd and lung cancer through mendelian randomization analysis and scrna seq data integration
topic scRNA-seq
Mendelian randomization
Lung cancer
Regulatory T cells
Chronic obstructive Pulmonary disease
url https://doi.org/10.1186/s12885-024-12076-1
work_keys_str_mv AT dengfengzhang exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration
AT haitaoliu exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration
AT fangchaozhao exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration
AT pengfeiguo exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration
AT jingli exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration
AT tianxinglu exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration
AT zhirongli exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration
AT shujunli exploringtherelationshipbetweentregmediatedriskincopdandlungcancerthroughmendelianrandomizationanalysisandscrnaseqdataintegration